From investments in cutting-edge technology to successful portfolio company exits and development milestones, the 2024 UPMC Enterprises Year in Review report outlines our numerous accomplishments from the past year.
As the innovation, commercialization, and venture capital division of the UPMC system, UPMC Enterprises hold a unique position within the UPMC payer and provider network. We partner with clinicians and other experts across the system to drive innovation that supports the mission of UPMC, now and into the future.
To accomplish this work, we identify the biggest challenges our colleagues across the system face and deliver technology and scientific discoveries that can address those problems.
Read on for a summary of achievements from UPMC Enterprises, our portfolio companies, and our initiatives that support the mission and vision of UPMC.
A Growing Portfolio Focused on Key Areas of Health Care Innovation
With more than 40 active investments in early- to late-stage growth-stage companies, UPMC Enterprises is constantly seeking out impactful technologies, transformative therapies, and forward-thinking entrepreneurs that are tackling some of the biggest challenges in health care.
Among this year’s newest investments were Elektra Health, Medicom, Sudo Biosciences, ThriveAP, and Ultromics. Each new company supports our commitment to furthering health care innovation.
Portfolio Exits Demonstrate Value of UPMC Enterprises’ Model
The strength of the UPMC Enterprises model of delivering innovative solutions to health care is validated through successful exits from our portfolio. We are proud to see two initiatives move to the next stage in their journey. First, a home-grown teleconsult technology platform that we developed was acquired by eVisit. And second, Signallamp, a remote chronic care management company, merged with Accuhealth. We wish these companies continued success in the future.
Marking Milestones: Attracting Investments, Clinical Advances, Productive Partnerships
Our portfolio and other projects across the Digital Solutions and Translational Sciences focus areas continued to advance innovation, with the help of our leaders at Enterprises and advisors from across the UPMC system.
Over the past year, we recognized many significant milestones, including several successful fundraising rounds for portfolio companies such as Abridge, BrainCheck, and Pip Care, and positive clinical developments for BlueSphere Bio, Cerevance, Mozart Therapeutics, Noema Pharma, and SparingVision.
Showcasing Our Expertise
Our leaders and experts speak at many high-profile industry events each year, where we share not only our unique experience and expertise but also our insights into trends and developments in health care investing and innovation.
We were represented in many in-person and virtual events throughout 2024, including BIO International Convention, HLTH, and ViVE. Experts from UPMC Enterprises were featured guests on two expert panel discussion webinars facilitated by the Center for Connected Medicine. In addition, we partnered with the Center for Connected Medicine to host two Top of Mind Summit events — one focused on digital health and the other on life sciences.
In the News
Between mentions of UPMC Enterprises, our executives, and our portfolio companies, we were cited in nearly 400 news articles this year. A broad range of topics were covered and UPMC experts featured in publications including The Wall Street Journal, Becker’s Hospital Review, Modern Healthcare, Pittsburgh Business Times, Fierce Healthcare, and more.
Next Steps
- Download the Year in Review report for the full story of 2024.
- Sign up to receive Small Bytes, a quarterly newsletter from UPMC Enterprises, to stay up to date on our latest news.
